A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD)

Publisher Website
Google Scholar
Abstract
In a prospective, randomized, controlled trial in 40 patients, intraperitoneal ciprof-loxacin was shown to be as effective as the currently recommended regimen of intraperitoneal vancomycin and gentamicin for the treatment of CAPD peritonitis. There was one treatment failure in the dprofloxacin arm and four in the comparative arm. A single drug regimen is preferred by patients. The intraperitoneal route of administration of dprofloxacin therapy has advantages over the oral route.

This publication has 0 references indexed in Scilit: